X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (219) 219
index medicus (191) 191
microbiology (124) 124
animals (109) 109
glycopeptides (96) 96
vancomycin (78) 78
anti-bacterial agents - pharmacology (77) 77
glycopeptide resistance (77) 77
antibiotics (74) 74
female (61) 61
microbial sensitivity tests (61) 61
anti-bacterial agents - therapeutic use (60) 60
biotechnology & applied microbiology (57) 57
food science & technology (57) 57
male (57) 57
pharmacology & pharmacy (53) 53
infectious diseases (52) 52
drug resistance in microorganisms (48) 48
analysis (46) 46
middle aged (46) 46
research (45) 45
glycopeptide (43) 43
identification (42) 42
enterococcus - drug effects (41) 41
vancomycin resistance (41) 41
aged (40) 40
glycopeptides - blood (39) 39
glycopeptides - therapeutic use (38) 38
faecium (36) 36
peptides (35) 35
food microbiology (34) 34
glycopeptides - pharmacology (33) 33
antimicrobial resistance (31) 31
biomarkers - blood (31) 31
internal medicine (31) 31
glycosylation (30) 30
infections (30) 30
resistant staphylococcus-aureus (30) 30
adult (29) 29
bacteria (29) 29
drug resistance (29) 29
enterococcus (29) 29
glycopeptides - chemistry (29) 29
antibiotic resistance (28) 28
proteins (28) 28
biochemical phenomena, metabolism, and nutrition (26) 26
biochemistry & molecular biology (26) 26
drug resistance, bacterial (26) 26
enterococcus - isolation & purification (26) 26
gram-positive bacterial infections - drug therapy (25) 25
health aspects (25) 25
molecular sequence data (25) 25
gram-positive bacterial infections - microbiology (24) 24
antibiotic-resistance (23) 23
glycopeptides - metabolism (23) 23
hospitals (23) 23
anti-bacterial agents - economics (22) 22
antimicrobial agents (22) 22
gram-positive bacteria (22) 22
mass spectrometry (22) 22
mortality (22) 22
staphylococcus-aureus (22) 22
vancomycin - pharmacology (22) 22
feces - microbiology (21) 21
teicoplanin (21) 21
anti-bacterial agents - administration & dosage (20) 20
anti-bacterial agents - adverse effects (20) 20
bacterial proteins - genetics (20) 20
cattle (20) 20
enterococcus - genetics (20) 20
poultry (20) 20
soft-tissue infections (20) 20
aged, 80 and over (19) 19
antibacterial agents (19) 19
care and treatment (19) 19
chemistry, applied (19) 19
enterococcus faecium - drug effects (19) 19
glycoproteins (19) 19
medicine & public health (19) 19
prospective studies (19) 19
public health microbiology (19) 19
staphylococcus aureus (19) 19
strains (19) 19
vancomycin resistance - genetics (19) 19
biochemical research methods (18) 18
copeptin (18) 18
drug resistance, multiple, bacterial (18) 18
enterococci (18) 18
enterococcus - classification (18) 18
epidemiology (18) 18
infection (18) 18
prevalence (18) 18
chemistry, organic (17) 17
drug resistance, microbial (17) 17
enterococcus faecium - genetics (17) 17
enterococcus-faecium (17) 17
escherichia-coli (17) 17
physiological aspects (17) 17
amino acid sequence (16) 16
article (16) 16
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (396) 396
French (4) 4
Italian (1) 1
Japanese (1) 1
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The European Journal of Health Economics, ISSN 1618-7598, 2/2010, Volume 11, Issue 1, pp. 57 - 66
Aim Surgical site infection is commonly caused by staphylococcus aureus. The multiresistant strains (MRSA) are resistant to most antibiotic prophylaxis... 
Unit costs | Economic models | Antibiotics | Cephalosporins | Mortality | Infections | Arthroplasty | Glycopeptides | Staphylococcus aureus | Cost efficiency | I19 | Economic Policy | Economic model | Glycopeptide | Methicillin-resistant Staphylococcus aureus | Surgical site infection | Public Finance & Economics | Antimicrobial prophylaxis | Public Health/Gesundheitswesen | Economics / Management Science | COST-EFFECTIVENESS | VACCINATION PROGRAMS | ARTHROPLASTY | RESISTANT STAPHYLOCOCCUS-AUREUS | ANTIMICROBIAL RESISTANCE | CARE | HIP | IMPACT | SURGICAL SITE | VANCOMYCIN | HEALTH POLICY & SERVICES | ECONOMICS | Confidence Intervals | Antibiotic Prophylaxis - statistics & numerical data | Length of Stay - economics | Humans | Cephalosporins - economics | Models, Economic | Glycopeptides - economics | Methicillin-Resistant Staphylococcus aureus | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination | Odds Ratio | Length of Stay - statistics & numerical data | Anti-Bacterial Agents - economics | Quality-Adjusted Life Years | Surgical Wound Infection - economics | Decision Support Techniques | Surgical Wound Infection - mortality | Arthroplasty, Replacement, Hip | United Kingdom | Glycopeptides - therapeutic use | Vancomycin - economics | Surgical Wound Infection - prevention & control | Staphylococcal Infections - mortality | Staphylococcal Infections - economics | Vancomycin - therapeutic use | Staphylococcal Infections - prevention & control | Antibiotic Prophylaxis - economics | Moxalactam | Prevention | Drug resistance in microorganisms | Orthopedic surgery | Analysis | Pharmacy | Staphylococcus aureus infections | Cephaloridine | Models | Health aspects | Studies | Health economics | Economic theory | Nosocomial infections | Drug resistance
Journal Article
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 01/2015, Volume 104, Issue 1, pp. 2 - 14
Journal Article
Journal Article
Nephrology, ISSN 1320-5358, 11/2011, Volume 16, Issue 8, pp. 697 - 703
Aim:  Vancomycin and teicoplanin are the two most used glycopeptides for the treatment of methicillin‐resistant Staphylococcus aureus (MRSA). Vancomycin is... 
teicoplanin | hospital cost | vancomycin | acute kidney injury | Staphylococcus aureus | bacteraemia | Bacteraemia | Hospital cost | Vancomycin | Acute kidney injury | Teicoplanin | MORTALITY | INFECTIONS | GUIDELINES | NEUTROPENIC PATIENTS | FAILURE | PATHOGENESIS | THERAPY | UROLOGY & NEPHROLOGY | OUTCOMES | Length of Stay - economics | Humans | Middle Aged | Bacteremia - mortality | Male | Bacteremia - economics | Aged, 80 and over | Female | Acute Kidney Injury - chemically induced | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Length of Stay - statistics & numerical data | Anti-Bacterial Agents - economics | Hospital Costs - statistics & numerical data | Staphylococcal Infections - drug therapy | Vancomycin - administration & dosage | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Kaplan-Meier Estimate | Vancomycin - economics | Teicoplanin - adverse effects | Vancomycin - adverse effects | Staphylococcal Infections - mortality | Teicoplanin - economics | Acute Kidney Injury - mortality | Teicoplanin - administration & dosage | Acute Kidney Injury - economics | Staphylococcal Infections - economics | Aged | Anti-Bacterial Agents - administration & dosage | Drug resistance in microorganisms | Care and treatment | Chronic kidney failure | Comorbidity | Analysis | Staphylococcus aureus infections | Cross infection | Nosocomial infections | Medical care, Cost of | End-stage renal disease | Databases | Hospitals | Mortality | Classification | Data processing | Drug resistance | Glycopeptides | Bacteremia | Injuries | Index Medicus
Journal Article
Journal Article
American Journal of Emergency Medicine, ISSN 0735-6757, 02/2017, Volume 35, Issue 2, pp. 274 - 280
Journal Article